Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
American Vanguard Corporation (AVD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: AVD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $12
1 Year Target Price $12
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -71.85% | Avg. Invested days 16 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 110.94M USD | Price to earnings Ratio - | 1Y Target Price 12 |
Price to earnings Ratio - | 1Y Target Price 12 | ||
Volume (30-day avg) 1 | Beta 1.29 | 52 Weeks Range 3.28 - 9.84 | Updated Date 06/29/2025 |
52 Weeks Range 3.28 - 9.84 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -4.86 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -25.83% | Operating Margin (TTM) -1.83% |
Management Effectiveness
Return on Assets (TTM) -3.66% | Return on Equity (TTM) -45.53% |
Valuation
Trailing PE - | Forward PE 15.08 | Enterprise Value 285690761 | Price to Sales(TTM) 0.21 |
Enterprise Value 285690761 | Price to Sales(TTM) 0.21 | ||
Enterprise Value to Revenue 0.54 | Enterprise Value to EBITDA 10.49 | Shares Outstanding 28228400 | Shares Floating 26562077 |
Shares Outstanding 28228400 | Shares Floating 26562077 | ||
Percent Insiders 7.95 | Percent Institutions 72.1 |
Analyst Ratings
Rating 1 | Target Price 12 | Buy - | Strong Buy 1 |
Buy - | Strong Buy 1 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
American Vanguard Corporation
Company Overview
History and Background
American Vanguard Corporation was founded in 1969. Initially focused on distributing specialty chemicals, it evolved into a developer and manufacturer of crop protection, specialty products, and public and animal health products. Key milestones include strategic acquisitions expanding its product portfolio and global reach.
Core Business Areas
- Crop Protection: Develops, manufactures, and markets crop protection products, including insecticides, herbicides, fungicides, and soil fumigants, targeting various agricultural crops.
- Environmental Science: Provides products for professional pest control, public health, and animal health markets. Products include insecticides, rodenticides, and other specialty chemical solutions.
- International: Conducts business through AMVAC Netherlands B.V. for the European markets
Leadership and Structure
Eric Wintemute serves as the Chairman and CEO. The company operates with a functional organizational structure, with departments focused on sales, marketing, research and development, manufacturing, and finance.
Top Products and Market Share
Key Offerings
- Bidrin 8: A systemic insecticide used to control various pests in cotton and other crops. Market share varies by region and crop, but is a leading brand in its niche. Competitors include generic formulations of similar active ingredients and alternative pest control methods. Specific revenue from this product is not publicly disclosed. Competitors: Bayer, Syngenta
- Fumigants: Offers soil fumigants for nematode and soilborne disease control. Competes with products from companies like ADAMA and Corteva Agriscience. Market share varies by region and crop; Specific revenue from this product is not publicly disclosed. Competitors: ADAMA, Corteva Agriscience
- Dibrom: A broad-spectrum insecticide used for mosquito control and crop protection in various countries. Specific revenue and market share data not available. Competitors: Bayer, Clarke Mosquito Control
Market Dynamics
Industry Overview
The crop protection industry is characterized by consolidation, innovation in crop technology (GMOs, precision agriculture), regulatory pressures, and increasing demand for sustainable agricultural practices. Environmental science is impacted by public health concerns and vector-borne disease control.
Positioning
American Vanguard is a mid-sized player focused on niche markets and specialty products. Its competitive advantages include a strong product portfolio, established distribution channels, and expertise in formulation and registration of chemical products. They are well-positioned in the pesticide/insecticide market.
Total Addressable Market (TAM)
The global crop protection market is estimated at over $80 billion. American Vanguard's TAM is the portion focusing on specialty products and select geographies. Their positioning within this market allows them to capture a portion of the overall market through niche solutions.
Upturn SWOT Analysis
Strengths
- Strong product portfolio in niche markets
- Established distribution channels
- Expertise in formulation and registration
- Agility to innovate and respond to market needs
Weaknesses
- Smaller scale compared to major players
- Limited R&D budget relative to competitors
- Vulnerable to regulatory changes
- Dependence on specific active ingredients
Opportunities
- Acquisitions of complementary businesses
- Expansion into new geographies
- Development of biological crop protection products
- Leveraging precision agriculture technologies
Threats
- Increasing regulatory scrutiny
- Generic competition
- Development of resistant pests
- Fluctuations in commodity prices
Competitors and Market Share
Key Competitors
- Corteva (CTVA)
- Bayer (BAYRY)
- Syngenta (SNYNY)
Competitive Landscape
American Vanguard competes with larger, more diversified companies. Its strength lies in niche markets and specialty products, while its challenges include limited R&D resources and competitive pressure from generics.
Major Acquisitions
OHP, Inc.
- Year: 2017
- Acquisition Price (USD millions): 13.7
- Strategic Rationale: The acquisition of OHP broadens American Vanguardu2019s penetration into the professional horticulture market.
Hercon Environmental
- Year: 2020
- Acquisition Price (USD millions): 17.5
- Strategic Rationale: Herconu2019s proprietary delivery systems and products are synergistic with AMVACu2019s current portfolio in its Environmental Science business.
Growth Trajectory and Initiatives
Historical Growth: Describe American Vanguard's growth trends over the past years, considering revenue growth, profitability, and market share.
Future Projections: Consult analyst estimates for future revenue growth, earnings per share, and other relevant metrics.
Recent Initiatives: Identify recent acquisitions, product launches, strategic partnerships, and other initiatives.
Summary
American Vanguard is a mid-sized player in the crop protection and environmental science sectors, leveraging niche markets. Its strength lies in specialty products and established distribution. Key challenges include competition from larger entities and regulatory pressures. Recent acquisitions enhance its portfolio, but sustained growth depends on innovation and strategic execution.
Peer Comparison
Sources and Disclaimers
Data Sources:
- American Vanguard Corporation Investor Relations
- SEC Filings
- Industry Reports
- Analyst Estimates
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice. Market conditions and company performance can change rapidly. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Vanguard Corporation
Exchange NYSE | Headquaters Newport Beach, CA, United States | ||
IPO Launch date 1988-06-22 | Chairman & CEO Mr. Douglas A. Kaye III CPA | ||
Sector Basic Materials | Industry Agricultural Inputs | Full time employees 755 | |
Full time employees 755 | |||
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets chemical, biological and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. It synthesizes and formulates chemicals, and ferments and extracts microbial products, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf, ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes products for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.